propranolol has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine-treated NSCLC cells showed significant induction of the α7nAChR and α4nAChR, along with significant inductions of p-CREB and p-ERK1/2 accompanied by increases in the stress neurotransmitter noradrenaline, which in turn led to the observed increase in DNA synthesis and cell proliferation." | 1.38 | Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. ( Al-Wadei, HA; Al-Wadei, MH; Schuller, HM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sidorova, M | 1 |
| Petrikaitė, V | 1 |
| Ray, R | 1 |
| Al Khashali, H | 1 |
| Haddad, B | 1 |
| Wareham, J | 1 |
| Coleman, KL | 1 |
| Alomari, D | 1 |
| Ranzenberger, R | 1 |
| Guthrie, J | 1 |
| Heyl, D | 1 |
| Evans, HG | 1 |
| Wang, H | 1 |
| Gomez, DR | 1 |
| Liao, Z | 1 |
| Al-Wadei, HA | 1 |
| Al-Wadei, MH | 1 |
| Schuller, HM | 1 |
4 other studies available for propranolol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
The Effect of Beta Adrenoreceptor Blockers on Viability and Cell Colony Formation of Non-Small Cell Lung Cancer Cell Lines A549 and H1299.
Topics: Adrenergic beta-Antagonists; Carcinoma, Non-Small-Cell Lung; Cell Line; Humans; Lung Neoplasms; Prop | 2022 |
Regulation of Cisplatin Resistance in Lung Cancer Cells by Nicotine, BDNF, and a β-Adrenergic Receptor Blocker.
Topics: Adrenergic Antagonists; Brain-Derived Neurotrophic Factor; Carcinoma, Non-Small-Cell Lung; Cell Line | 2022 |
β-Blockers and metastasis in non-small-cell lung cancer.
Topics: Adrenergic beta-Antagonists; Animals; Carcinoma, Non-Small-Cell Lung; gamma-Aminobutyric Acid; Human | 2013 |
Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Lin | 2012 |